Graf Akcie CLDX (Celldex Therapeutics Inc.). Diskuze k akciím CLDX. Aktuální informace CLDX.

Základní informace o společnosti Celldex Therapeutics Inc. (Akcie CLDX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	1.86B
Hodnota podniku (EV)	2.26B
Tržby	8.618M
EBITDA	-50.13
Zisk	-66.04
Růst v tržbách Q/Q	1,374.58 %
Růst v tržbách Y/Y	96.00 %
P/E (Cena vůči ziskům)	N/A
Forward P/E	-136.21
EV/Sales	261.97
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	215.26
P/FCF	N/A
Price/Book	8.86
Účetní hodnota na akcii	5.28
Hotovost na akcii	4.91
FCF vůči ceně	-2.60 %
Počet zaměstnanců	124
Tržba na zaměstnance	69.500k
Profit margin	-805.88 %
Operating margin	-786.50 %
Gross margin	100.00 %
EBIT margin	-777.14 %
EBITDA margin	-581.63 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-32.00 %
EPS - Očekávaný růst příští rok	2.78 %
Return on assets	-28.86 %
Return on equity	-32.38 %
ROIC	-33.98 %
ROCE	-35.24 %
Dluhy/Equity	0.13
Čistý dluh/EBITDA	14.38
Current ratio	11.57
Quick Ratio	11.57
Volatilita	5.14
Beta	1.14
RSI	34.77
Cílová cena analytiků	26
Známka akcie (dle analytiků)	1.00
Insider ownership	4.55 %
Institutional ownership	78.23 %
Počet akcií	46.482M
Procento shortovaných akcií	9.32 %
Short ratio	4.16 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	1986
Země	United States

Finanční výsledky akcie CLDX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$3.573	$9.538	$12.743	$6.786	$5.48	$3.586
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	$3.573	$9.538	$12.743	$6.786	$5.48	$3.586
Research And Development Expenses	$42.672	$66.449	$96.171	$102.726	$100.171	$104.381
SG&A Expenses	$15.426	$19.269	$25.003	$35.979	$33.837	$20.622
Other Operating Income Or Expenses	$-0.506	$10.944	$-12.2	-	-	-
Operating Expenses	$58.604	$165.974	$134.27	$139.702	$135.021	$126.016
Operating Income	$-55.031	$-156.436	$-121.527	$-132.916	$-129.541	$-122.43
Total Non-Operating Income/Expense	$4.153	$4.487	$4.214	$4.386	$2.344	$4.35
Pre-Tax Income	$-50.878	$-151.949	$-117.313	$-128.53	$-127.197	$-118.08
Income Taxes	-	$-0.765	$-24.282	-	-	-
Income After Taxes	$-50.878	$-151.184	$-93.031	$-128.53	$-127.197	$-118.08
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-50.878	$-151.184	$-93.031	$-128.53	$-127.197	$-118.08
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-50.878	$-151.184	$-93.031	$-128.53	$-127.197	$-118.08
EBITDA	$-51.313	$-62.707	$-116.507	$-127.898	$-125.18	$-118.934
EBIT	$-55.031	$-156.436	$-121.527	$-132.916	$-129.541	$-122.43
Basic Shares Outstanding	15	10	9	7	6	6
Shares Outstanding	15	10	9	7	6	6
Basic EPS	$-3.51	$-14.48	$-10.86	$-18.99	$-19.64	$-19.79
EPS - Earnings Per Share	$-3.51	$-14.48	$-10.86	$-18.99	$-19.64	$-19.79

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$64.383	$94.022	$139.427	$189.776	$289.889	$201.043
Receivables	$1.015	$3.162	$1.88	$1.784	$0.97	$0.427
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$1.3	$1.895	$3.449	$4.009	$4.077	$3.515
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$66.698	$99.079	$144.756	$195.569	$294.936	$204.985
Property, Plant, And Equipment	$4.031	$6.111	$10.372	$13.192	$11.461	$10.535
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	$48.69	$48.69	$158.567	$172.463	$29.759	$30.772
Other Long-Term Assets	$0.041	$1.929	$1.929	$2.134	$1.428	$1.722
Total Long-Term Assets	$56.235	$56.73	$170.868	$187.789	$42.648	$43.029
Total Assets	$122.933	$155.809	$315.624	$383.358	$337.584	$248.014
Total Current Liabilities	$11.643	$12.602	$27.736	$35.223	$30.24	$24.491
Long Term Debt	-	-	-	-	-	-
Other Non-Current Liabilities	$15.551	$19.147	$51.519	$82.704	$17.239	$11.863
Total Long Term Liabilities	$17.264	$19.147	$51.519	$82.704	$17.239	$11.863
Total Liabilities	$28.907	$31.749	$79.255	$117.927	$47.479	$36.354
Common Stock Net	$0.017	$0.012	$0.009	$0.121	$0.099	$0.09
Retained Earnings (Accumulated Deficit)	$-1,013.316	$-962.438	$-812.517	$-719.486	$-590.956	$-463.759
Comprehensive Income	$2.619	$2.583	$2.564	$2.541	$2.307	$2.59
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$94.026	$124.06	$236.369	$265.431	$290.105	$211.66
Total Liabilities And Share Holders Equity	$122.933	$155.809	$315.624	$383.358	$337.584	$248.014

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-50.878	$-151.184	$-93.031	$-128.53	$-127.197	$-118.08
Total Depreciation And Amortization - Cash Flow	$3.718	$93.729	$5.02	$5.018	$4.361	$3.496
Other Non-Cash Items	$5.068	$-2.408	$0.285	$17.036	$13.062	$6.919
Total Non-Cash Items	$8.786	$91.321	$5.305	$22.054	$17.423	$10.415
Change In Accounts Receivable	$2.274	$-0.777	$-0.096	$-0.814	$-0.543	$0.062
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-	-
Change In Assets/Liabilities	$-6.276	$-1.485	$-3.365	$-0.776	$6.555	$4.616
Total Change In Assets/Liabilities	$-4.323	$-15.372	$-12.205	$-6.56	$10.887	$6.128
Cash Flow From Operating Activities	$-46.415	$-75.235	$-99.931	$-113.036	$-98.887	$-101.537
Net Change In Property, Plant, And Equipment	$-0.711	$-0.471	$-1.788	$-2.751	$-4.876	$-1.929
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	$4.592	-	-
Net Change In Short-term Investments	$17.791	$30.287	$48.256	$67.066	$-45.315	$-39.082
Net Change In Long-Term Investments	-	-	-	-	-	-
Net Change In Investments - Total	$17.791	$30.287	$48.256	$67.066	$-45.315	$-39.082
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$17.08	$29.816	$46.468	$68.907	$-50.191	$-41.011
Net Long-Term Debt	-	-	-	-	-	-
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	-	-	-	-	-	-
Net Common Equity Issued/Repurchased	$16.257	$29.441	$51.29	$14.482	$193.151	$1.171
Net Total Equity Issued/Repurchased	$16.257	$29.441	$51.29	$14.482	$193.151	$1.171
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	-	-	-	-	-	-
Cash Flow From Financial Activities	$16.257	$29.441	$51.29	$14.482	$193.151	$1.171
Net Cash Flow	$-13.078	$-15.978	$-2.173	$-29.647	$44.088	$-141.382
Stock-Based Compensation	$4.551	$8.081	$12.312	$15.317	$12.774	$6.852
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	5.7286	7.8622	5.2191	5.5523	9.7532	8.3698
Long-term Debt / Capital	-	-	-	-	-	-
Debt/Equity Ratio	-	-	0.0278	0.0182	-	-
Gross Margin	100	100	100	100	100	100
Operating Margin	-1540.19	-1640.134	-953.6766	-1958.68	-2363.887	-3414.111
EBIT Margin	-1540.19	-1640.134	-953.6766	-1958.68	-2363.887	-3414.111
EBITDA Margin	-1436.132	-657.4438	-914.2824	-1884.733	-2284.307	-3316.62
Pre-Tax Profit Margin	-1423.957	-1593.091	-920.6074	-1894.047	-2321.113	-3292.805
Net Profit Margin	-1423.957	-1585.07	-730.0557	-1894.047	-2321.113	-3292.805
Asset Turnover	0.0291	0.0612	0.0404	0.0177	0.0162	0.0145
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	3.5202	3.0164	6.7782	3.8038	5.6495	8.3981
Days Sales In Receivables	103.6874	121.0033	53.8492	95.9564	64.6077	43.4621
ROE - Return On Equity	-54.1105	-121.8637	-39.3584	-48.4231	-43.8452	-55.7876
Return On Tangible Equity	-112.2243	-200.5891	-119.5741	-138.2519	-48.8569	-65.278
ROA - Return On Assets	-41.3868	-97.0316	-29.4753	-33.5274	-37.6786	-47.6102
ROI - Return On Investment	-54.1106	-121.8636	-39.3584	-48.4231	-43.8452	-55.7876
Book Value Per Share	5.5401	10.3746	25.5949	33.02	44.0731	35.4192
Operating Cash Flow Per Share	4.0055	4.4556	5.0385	-1.423	1.752	-4.311
Free Cash Flow Per Share	4.0016	4.6191	5.2363	-1.0761	1.3222	-3.8456

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/CLDX', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie CLDX (Celldex Therapeutics Inc.). Diskuze k akciím CLDX. Aktuální informace CLDX.

Základní informace o společnosti Celldex Therapeutics Inc. (Akcie CLDX)

Finanční výsledky akcie CLDX